[Viferon efficacy in influenza in adult patients].
The therapeutic efficacy of Viferon (suppositories of human recombinant interferon alfa-2) was investigated in a double-blind controlled study with the use of Arbidol as a reference drug in the treatment of patients with influenza. Viferon and Arbidol lowered the signs of the fever, intoxication, catarrh and the disease as the whole.
Vasil'ev
A N
AN
Gatich
R Z
RZ
Kolobukhina
L V
LV
Isaeva
E I
EI
Burtseva
E I
EI
Orlova
T G
TG
Voronina
F V
FV
Malinovskaia
V V
VV
D000293:Adolescent; D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007211:Indoles / Q000009:adverse effects / Q000627:therapeutic use*; D007251:Influenza, Human / Q000188:drug therapy*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D013488:Suppositories; D016896:Treatment Outcome; D013440:Sulfides
D000998:Antiviral Agents; D007211:Indoles; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D013488:Suppositories; C086979:umifenovir; D013440:Sulfides